Warning! GuruFocus detected
6 Severe warning signs
with 6IV.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Inventiva SA
ISIN : FR0013233012
Compare
Compare
Traded in other countries / regions
IVA.FranceIVA.USA0RNK.UK6IV.Germany IPO Date
2020-07-13Description
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | -2.01 | |||||
| Debt-to-Equity | -0.67 | |||||
| Debt-to-EBITDA | -0.55 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -5.51 | |||||
| Beneish M-Score | -0.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 227.1 | |||||
| 3-Year EBITDA Growth Rate | -34 | |||||
| 3-Year EPS without NRI Growth Rate | -41 | |||||
| 3-Year FCF Growth Rate | -25.7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.05 | |||||
| 9-Day RSI | 50.34 | |||||
| 14-Day RSI | 53.12 | |||||
| 3-1 Month Momentum % | 32.13 | |||||
| 6-1 Month Momentum % | 70.69 | |||||
| 12-1 Month Momentum % | -16.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.59 | |||||
| Quick Ratio | 0.59 | |||||
| Cash Ratio | 0.21 | |||||
| Days Sales Outstanding | 90.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.5 | |||||
| Shareholder Yield % | -15.53 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1060.63 | |||||
| Net Margin % | -2002.74 | |||||
| FCF Margin % | -927.25 | |||||
| ROE % | -1642.63 | |||||
| ROA % | -307.35 | |||||
| ROIC % | -445.49 | |||||
| 3-Year ROIIC % | -507.57 | |||||
| ROC (Joel Greenblatt) % | -1188.85 | |||||
| ROCE % | -669.67 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 18.83 | |||||
| EV-to-EBIT | -2.96 | |||||
| EV-to-Forward-EBIT | -2.41 | |||||
| EV-to-EBITDA | -3.02 | |||||
| EV-to-Forward-EBITDA | -2.46 | |||||
| EV-to-Revenue | 31.41 | |||||
| EV-to-Forward-Revenue | 31.35 | |||||
| EV-to-FCF | -3.39 | |||||
| Price-to-GF-Value | 0.13 | |||||
| Earnings Yield (Greenblatt) % | -33.78 | |||||
| FCF Yield % | -34.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inventiva SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 9.198 | ||
| EPS (TTM) (€) | -3.08 | ||
| Beta | 0.33 | ||
| 3-Year Sharpe Ratio | -0.22 | ||
| 3-Year Sortino Ratio | -0.35 | ||
| Volatility % | 79.41 | ||
| 14-Day RSI | 53.12 | ||
| 14-Day ATR (€) | 0.054567 | ||
| 20-Day SMA (€) | 2.724 | ||
| 12-1 Month Momentum % | -16.77 | ||
| 52-Week Range (€) | 1.448 - 3.605 | ||
| Shares Outstanding (Mil) | 95.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inventiva SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inventiva SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inventiva SA Frequently Asked Questions
What is Inventiva SA(FRA:6IV)'s stock price today?
The current price of FRA:6IV is €2.72. The 52 week high of FRA:6IV is €3.61 and 52 week low is €1.45.
When is next earnings date of Inventiva SA(FRA:6IV)?
The next earnings date of Inventiva SA(FRA:6IV) is 2025-09-25 Est..
Does Inventiva SA(FRA:6IV) pay dividends? If so, how much?
Inventiva SA(FRA:6IV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers